A signature trial?
نویسندگان
چکیده
منابع مشابه
A Novel Patch-Based Digital Signature
In this paper a new patch-based digital signature (DS) is proposed. The proposed approach similar to steganography methods hides the secure message in a host image. However, it uses a patch-based key to encode/decode the data like cryptography approaches. Both the host image and key patches are randomly initialized. The proposed approach consists of encoding and decoding algorithms. The encodin...
متن کاملGastric Cancer MicroRNAs Meta-signature
Gastric cancer (GC) is one of the most common types of cancer and the second leading cause of cancer-associated mortality. Identification of novel biomarkers is critical to prolonging patient survival. MicroRNAs (miRNAs) proved to play diverse roles in the physiological and pathological state in cancers including GC. Herein we were aimed at performing a meta-analysis on miRNA profiling studies ...
متن کاملSignature submanifolds for some equivalence problems
This article concerned on the study of signature submanifolds for curves under Lie group actions SE(2), SA(2) and for surfaces under SE(3). Signature submanifold is a regular submanifold which its coordinate components are differential invariants of an associated manifold under Lie group action, and therefore signature submanifold is a key for solving equivalence problems.
متن کاملAdaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients.
PURPOSE A new generation of molecularly targeted agents is entering the definitive stage of clinical evaluation. Many of these drugs benefit only a subset of treated patients and may be overlooked by the traditional, broad-eligibility approach to randomized clinical trials. Thus, there is a need for development of novel statistical methodology for rapid evaluation of these agents. EXPERIMENTA...
متن کاملA Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma
Background. Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with rapid tumor progression and poor prognosis. This study was motivated by the lack of sensitive and specific PDAC biomarkers and aimed to identify a diagnostic, serum protein signature for PDAC. Methods. To mimic a real life test situation, a multicenter trial comprising a serum sample cohort, including 338 patients...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Clinical Practice Urology
سال: 2008
ISSN: 1743-4270,1743-4289
DOI: 10.1038/ncpuro1240